Does the media favor ESTA or TCMD?

In the previous week, Establishment Labs and Establishment Labs both had 2 articles in the media. Establishment Labs' average media sentiment score of 0.94 beat Tactile Systems Technology's score of 0.93 indicating that Establishment Labs is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Establishment Labs 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer TMDX or TCMD?

In the previous week, TransMedics Group had 4 more articles in the media than Tactile Systems Technology. MarketBeat recorded 6 mentions for TransMedics Group and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.93 beat TransMedics Group's score of 0.65 indicating that Tactile Systems Technology is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment TransMedics Group 3 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor AXGN or TCMD?

In the previous week, AxoGen had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 4 mentions for AxoGen and 2 mentions for Tactile Systems Technology. AxoGen's average media sentiment score of 1.08 beat Tactile Systems Technology's score of 0.93 indicating that AxoGen is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AxoGen 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media refer more to TCMD or LMAT?

In the previous week, LeMaitre Vascular had 3 more articles in the media than Tactile Systems Technology. MarketBeat recorded 5 mentions for LeMaitre Vascular and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.93 beat LeMaitre Vascular's score of 0.41 indicating that Tactile Systems Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LeMaitre Vascular 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media prefer TCMD or NVCR?

In the previous week, NovoCure had 6 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for NovoCure and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.93 beat NovoCure's score of 0.51 indicating that Tactile Systems Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Tactile Systems Technology 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive NovoCure 0 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Tactile Systems Technology (TCMD) Competitors

$28.16 -0.88 (-3.02%)

As of 10:17 AM Eastern

Compare

TCMD vs. ESTA, TMDX, AXGN, LMAT, and NVCR

Should you buy Tactile Systems Technology stock or one of its competitors? MarketBeat compares Tactile Systems Technology with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Tactile Systems Technology include Establishment Labs (ESTA), TransMedics Group (TMDX), AxoGen (AXGN), LeMaitre Vascular (LMAT), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry.

How does Tactile Systems Technology compare to Establishment Labs?

Establishment Labs (NASDAQ:ESTA) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their valuation, earnings, media sentiment, profitability, analyst recommendations, risk, institutional ownership and dividends.

Tactile Systems Technology has higher revenue and earnings than Establishment Labs. Establishment Labs is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Establishment Labs	$211.08M	11.83	-$51.06M	-$1.49	N/A
Tactile Systems Technology	$329.52M	1.93	$19.09M	$0.88	32.00

In the previous week, Establishment Labs and Establishment Labs both had 2 articles in the media. Establishment Labs' average media sentiment score of 0.94 beat Tactile Systems Technology's score of 0.93 indicating that Establishment Labs is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Establishment Labs	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

72.9% of Establishment Labs shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 10.0% of Establishment Labs shares are held by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

Establishment Labs currently has a consensus target price of $89.71, suggesting a potential upside of 5.75%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 37.06%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, analysts clearly believe Tactile Systems Technology is more favorable than Establishment Labs.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Establishment Labs	1 Sell rating(s)	1 Hold rating(s)	7 Buy rating(s)	0 Strong Buy rating(s)	2.67
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

Establishment Labs has a beta of 1.06, suggesting that its stock price is 6% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market.

Tactile Systems Technology has a net margin of 5.91% compared to Establishment Labs' net margin of -19.05%. Tactile Systems Technology's return on equity of 9.70% beat Establishment Labs' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Establishment Labs	-19.05%	-218.77%	-12.31%
Tactile Systems Technology	5.91%	9.70%	7.53%

Summary

Tactile Systems Technology beats Establishment Labs on 11 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to TransMedics Group?

TransMedics Group (NASDAQ:TMDX) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, media sentiment, earnings, analyst recommendations and profitability.

TransMedics Group has a beta of 1.89, suggesting that its stock price is 89% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.79, suggesting that its stock price is 21% less volatile than the broader market.

TransMedics Group presently has a consensus target price of $134.50, suggesting a potential upside of 80.48%. Tactile Systems Technology has a consensus target price of $38.60, suggesting a potential upside of 37.06%. Given TransMedics Group's higher possible upside, equities analysts clearly believe TransMedics Group is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
TransMedics Group	1 Sell rating(s)	6 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.38
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

TransMedics Group has a net margin of 27.04% compared to Tactile Systems Technology's net margin of 5.91%. TransMedics Group's return on equity of 22.38% beat Tactile Systems Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
TransMedics Group	27.04%	22.38%	8.46%
Tactile Systems Technology	5.91%	9.70%	7.53%

99.7% of TransMedics Group shares are held by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are held by institutional investors. 6.9% of TransMedics Group shares are held by company insiders. Comparatively, 2.1% of Tactile Systems Technology shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

In the previous week, TransMedics Group had 4 more articles in the media than Tactile Systems Technology. MarketBeat recorded 6 mentions for TransMedics Group and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.93 beat TransMedics Group's score of 0.65 indicating that Tactile Systems Technology is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
TransMedics Group	3 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

TransMedics Group has higher revenue and earnings than Tactile Systems Technology. TransMedics Group is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
TransMedics Group	$605.49M	4.25	$190.29M	$4.40	16.94
Tactile Systems Technology	$329.52M	1.93	$19.09M	$0.88	32.00

Summary

TransMedics Group beats Tactile Systems Technology on 13 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to AxoGen?

AxoGen (NASDAQ:AXGN) and Tactile Systems Technology (NASDAQ:TCMD) are both medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, analyst recommendations, profitability, dividends, institutional ownership, earnings, media sentiment and valuation.

Tactile Systems Technology has a net margin of 5.91% compared to AxoGen's net margin of -13.21%. Tactile Systems Technology's return on equity of 9.70% beat AxoGen's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
AxoGen	-13.21%	-9.63%	-6.26%
Tactile Systems Technology	5.91%	9.70%	7.53%

In the previous week, AxoGen had 2 more articles in the media than Tactile Systems Technology. MarketBeat recorded 4 mentions for AxoGen and 2 mentions for Tactile Systems Technology. AxoGen's average media sentiment score of 1.08 beat Tactile Systems Technology's score of 0.93 indicating that AxoGen is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
AxoGen	1 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

AxoGen currently has a consensus price target of $46.50, indicating a potential upside of 19.10%. Tactile Systems Technology has a consensus price target of $38.60, indicating a potential upside of 37.06%. Given Tactile Systems Technology's stronger consensus rating and higher possible upside, analysts clearly believe Tactile Systems Technology is more favorable than AxoGen.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AxoGen	1 Sell rating(s)	1 Hold rating(s)	9 Buy rating(s)	0 Strong Buy rating(s)	2.73
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86

AxoGen has a beta of 1.09, suggesting that its share price is 9% more volatile than the broader market. Comparatively, Tactile Systems Technology has a beta of 0.79, suggesting that its share price is 21% less volatile than the broader market.

80.3% of AxoGen shares are owned by institutional investors. Comparatively, 83.4% of Tactile Systems Technology shares are owned by institutional investors. 2.4% of AxoGen shares are owned by insiders. Comparatively, 2.1% of Tactile Systems Technology shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

Tactile Systems Technology has higher revenue and earnings than AxoGen. AxoGen is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
AxoGen	$225.21M	9.22	-$15.70M	-$0.64	N/A
Tactile Systems Technology	$329.52M	1.93	$19.09M	$0.88	32.00

Summary

Tactile Systems Technology beats AxoGen on 11 of the 17 factors compared between the two stocks.

How does Tactile Systems Technology compare to LeMaitre Vascular?

Tactile Systems Technology (NASDAQ:TCMD) and LeMaitre Vascular (NASDAQ:LMAT) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their dividends, analyst recommendations, profitability, risk, earnings, media sentiment, valuation and institutional ownership.

LeMaitre Vascular has a net margin of 24.35% compared to Tactile Systems Technology's net margin of 5.91%. LeMaitre Vascular's return on equity of 15.36% beat Tactile Systems Technology's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
LeMaitre Vascular	24.35%	15.36%	9.78%

LeMaitre Vascular has lower revenue, but higher earnings than Tactile Systems Technology. Tactile Systems Technology is trading at a lower price-to-earnings ratio than LeMaitre Vascular, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.93	$19.09M	$0.88	32.00
LeMaitre Vascular	$249.60M	8.95	$57.73M	$2.71	36.09

Tactile Systems Technology currently has a consensus price target of $38.60, suggesting a potential upside of 37.06%. LeMaitre Vascular has a consensus price target of $112.60, suggesting a potential upside of 15.13%. Given Tactile Systems Technology's stronger consensus rating and higher probable upside, equities analysts clearly believe Tactile Systems Technology is more favorable than LeMaitre Vascular.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
LeMaitre Vascular	0 Sell rating(s)	4 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50

In the previous week, LeMaitre Vascular had 3 more articles in the media than Tactile Systems Technology. MarketBeat recorded 5 mentions for LeMaitre Vascular and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.93 beat LeMaitre Vascular's score of 0.41 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LeMaitre Vascular	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Tactile Systems Technology has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, LeMaitre Vascular has a beta of 0.52, indicating that its share price is 48% less volatile than the broader market.

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 84.6% of LeMaitre Vascular shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by company insiders. Comparatively, 7.4% of LeMaitre Vascular shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Summary

LeMaitre Vascular beats Tactile Systems Technology on 10 of the 16 factors compared between the two stocks.

How does Tactile Systems Technology compare to NovoCure?

Tactile Systems Technology (NASDAQ:TCMD) and NovoCure (NASDAQ:NVCR) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, valuation, profitability, media sentiment, risk, dividends, earnings and institutional ownership.

Tactile Systems Technology has a net margin of 5.91% compared to NovoCure's net margin of -25.66%. Tactile Systems Technology's return on equity of 9.70% beat NovoCure's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Tactile Systems Technology	5.91%	9.70%	7.53%
NovoCure	-25.66%	-50.82%	-16.48%

In the previous week, NovoCure had 6 more articles in the media than Tactile Systems Technology. MarketBeat recorded 8 mentions for NovoCure and 2 mentions for Tactile Systems Technology. Tactile Systems Technology's average media sentiment score of 0.93 beat NovoCure's score of 0.51 indicating that Tactile Systems Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Tactile Systems Technology	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
NovoCure	0 Very Positive mention(s)	2 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Tactile Systems Technology has higher earnings, but lower revenue than NovoCure. NovoCure is trading at a lower price-to-earnings ratio than Tactile Systems Technology, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Tactile Systems Technology	$329.52M	1.93	$19.09M	$0.88	32.00
NovoCure	$655.35M	2.74	-$136.23M	-$1.53	N/A

Tactile Systems Technology has a beta of 0.79, indicating that its share price is 21% less volatile than the broader market. Comparatively, NovoCure has a beta of 0.94, indicating that its share price is 6% less volatile than the broader market.

83.4% of Tactile Systems Technology shares are held by institutional investors. Comparatively, 84.6% of NovoCure shares are held by institutional investors. 2.1% of Tactile Systems Technology shares are held by insiders. Comparatively, 5.5% of NovoCure shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Tactile Systems Technology presently has a consensus target price of $38.60, indicating a potential upside of 37.06%. NovoCure has a consensus target price of $23.60, indicating a potential upside of 52.11%. Given NovoCure's higher probable upside, analysts clearly believe NovoCure is more favorable than Tactile Systems Technology.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Tactile Systems Technology	0 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	1 Strong Buy rating(s)	2.86
NovoCure	1 Sell rating(s)	3 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

Tactile Systems Technology beats NovoCure on 10 of the 17 factors compared between the two stocks.

Get Tactile Systems Technology News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding TCMD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

TCMD vs. The Competition

Export

Metric	Tactile Systems Technology	MED INSTRUMENTS Industry	Medical Sector	NASDAQ Exchange
Market Cap	$640.14M	$7.41B	$6.76B	$12.50B
Dividend Yield	N/A	1.32%	2.68%	8.00%
P/E Ratio	32.24	49.94	26.93	24.41
Price / Sales	1.93	75.78	586.18	117.36
Price / Cash	25.90	26.85	29.22	49.36
Price / Book	2.87	7.20	10.94	6.33
Net Income	$19.09M	$162.30M	$3.58B	$330.66M
7 Day Performance	-10.57%	-1.61%	-2.10%	-0.66%
1 Month Performance	7.04%	-0.48%	3.21%	-0.14%
1 Year Performance	180.50%	3.46%	26.34%	20.16%

Tactile Systems Technology Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
TCMD Tactile Systems Technology	3.9765 of 5 stars	$28.16 -3.0%	$38.60 +37.1%	+191.6%	$640.14M	$329.52M	32.24	1,086	News Coverage
ESTA Establishment Labs	1.2964 of 5 stars	$90.14 -1.6%	$87.14 -3.3%	+95.8%	$2.65B	$211.08M	N/A	1,004	Analyst Forecast
TMDX TransMedics Group	4.3711 of 5 stars	$70.60 -0.9%	$134.50 +90.5%	-32.7%	$2.44B	$605.49M	16.04	210
AXGN AxoGen	3.2029 of 5 stars	$45.04 -2.0%	$46.50 +3.3%	+232.1%	$2.40B	$225.21M	N/A	450	Positive News
LMAT LeMaitre Vascular	3.9633 of 5 stars	$104.95 +1.2%	$112.60 +7.3%	+19.8%	$2.39B	$256.28M	38.66	490

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:TCMD) was last updated on 7/14/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Tactile Systems Technology (TCMD) Competitors

TCMD vs. ESTA, TMDX, AXGN, LMAT, and NVCR

How does Tactile Systems Technology compare to Establishment Labs?

Summary

How does Tactile Systems Technology compare to TransMedics Group?

Summary

How does Tactile Systems Technology compare to AxoGen?

Summary

How does Tactile Systems Technology compare to LeMaitre Vascular?

Summary

How does Tactile Systems Technology compare to NovoCure?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Tactile Systems Technology (TCMD) Competitors

TCMD vs. ESTA, TMDX, AXGN, LMAT, and NVCR

How does Tactile Systems Technology compare to Establishment Labs?

Which has preferable earnings & valuation, ESTA or TCMD?

Does the media favor ESTA or TCMD?

Do institutionals and insiders hold more shares of ESTA or TCMD?

Do analysts rate ESTA or TCMD?

Which has more risk and volatility, ESTA or TCMD?

Is ESTA or TCMD more profitable?

Summary

How does Tactile Systems Technology compare to TransMedics Group?

Which has more risk & volatility, TMDX or TCMD?

Do analysts prefer TMDX or TCMD?

Is TMDX or TCMD more profitable?

Do institutionals and insiders have more ownership in TMDX or TCMD?

Does the media prefer TMDX or TCMD?

Which has higher valuation and earnings, TMDX or TCMD?

Summary

How does Tactile Systems Technology compare to AxoGen?

Is AXGN or TCMD more profitable?

Does the media favor AXGN or TCMD?

Do analysts prefer AXGN or TCMD?

Which has more risk and volatility, AXGN or TCMD?

Do insiders & institutionals believe in AXGN or TCMD?

Which has stronger earnings and valuation, AXGN or TCMD?

Summary

How does Tactile Systems Technology compare to LeMaitre Vascular?

Is TCMD or LMAT more profitable?

Which has preferable valuation and earnings, TCMD or LMAT?

Do analysts prefer TCMD or LMAT?

Does the media refer more to TCMD or LMAT?

Which has more volatility and risk, TCMD or LMAT?

Do insiders and institutionals hold more shares of TCMD or LMAT?

Summary

How does Tactile Systems Technology compare to NovoCure?

Is TCMD or NVCR more profitable?

Does the media prefer TCMD or NVCR?

Which has stronger earnings & valuation, TCMD or NVCR?

Which has more volatility & risk, TCMD or NVCR?

Do institutionals & insiders hold more shares of TCMD or NVCR?

Do analysts rate TCMD or NVCR?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

TCMD vs. The Competition

Tactile Systems Technology Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools